{"filings":[{"id":523356,"accession_number":"0001193125-26-230425","cik":1668397,"company_name":"Medpace Holdings, Inc.","ticker":"MEDP","form_type":"8-K","filed_at":"2026-05-19T18:43:27+00:00","items":["5.03","5.07","9.01"],"status":"ready","headline":"Medpace shareholders approve charter amendments removing supermajority voting and special meeting restrictions","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Shareholders approved removal of supermajority voting requirements (24.3M for, 95k against); effective May 18, 2026.","Approved removal of limitation on stockholders calling special meetings; new bylaws require 25% continuous ownership for one year.","Non-binding stockholder proposal on special meetings defeated (8.3M for, 16.1M against); board recommended against.","Advisory say-on-pay passed (22.7M for, 1.7M against); frequency set to annual, consistent with board recommendation.","All five director nominees elected; Deloitte & Touche ratified as auditor for fiscal 2026."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":12744761023.361565,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":94549,"accession_number":"0001668397-26-000017","cik":1668397,"company_name":"Medpace Holdings, Inc.","ticker":"MEDP","form_type":"8-K","filed_at":"2026-04-22T23:59:59+00:00","items":["2.02","5.02","9.01"],"status":"ready","headline":"President Jesse Geiger resigns; CEO Troendle to reassume role; Q1 earnings results not available in filing","summary_kind":"llm","event_type":"leadership","confidence":"low","bullets":["Jesse Geiger to resign as President effective May 31, 2026; not due to disagreement.","CEO August Troendle will reassume President role until a successor is appointed.","Medpace announced Q1 2026 financial results on April 22, 2026, but the press release text was not included in the filing excerpt."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":12744761023.361565,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":107011,"accession_number":"0001668397-26-000004","cik":1668397,"company_name":"Medpace Holdings, Inc.","ticker":"MEDP","form_type":"8-K","filed_at":"2026-02-09T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Medpace reports Q4/FY2025 results; specific figures unavailable from filing","summary_kind":"llm","event_type":"earnings","confidence":"low","bullets":["Press release issued Feb 9, 2026 for quarter and year ended Dec 31, 2025.","No financial details or guidance changes provided in the 8-K body.","Exhibit 99.1 containing actual results is referenced but not appended in this text."],"consensus_eps_estimate":null,"consensus_eps_actual":15.28,"consensus_revenue_estimate":null,"consensus_revenue_actual":2530234000.0,"consensus_period":"2025-FY","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":12744761023.361565,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":123355,"accession_number":"0001668397-25-000108","cik":1668397,"company_name":"Medpace Holdings, Inc.","ticker":"MEDP","form_type":"8-K","filed_at":"2025-10-22T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Medpace reports Q3 2025 earnings; press release unavailable for detail extraction","summary_kind":"llm","event_type":"earnings","confidence":"low","bullets":["Issued press release on October 22, 2025 announcing financial results for three and nine months ended September 30, 2025.","Press release furnished as Exhibit 99.1 but text not provided in this filing excerpt.","Results posted on company website; no specific revenue or EPS figures can be verified from given data."],"consensus_eps_estimate":null,"consensus_eps_actual":10.64,"consensus_revenue_estimate":null,"consensus_revenue_actual":1821784000.0,"consensus_period":"2025-Q3","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":12744761023.361565,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":140023,"accession_number":"0001668397-25-000085","cik":1668397,"company_name":"Medpace Holdings, Inc.","ticker":"MEDP","form_type":"8-K","filed_at":"2025-07-21T23:59:59+00:00","items":["1.01","2.02","9.01"],"status":"ready","headline":"Medpace reduces credit line to $10M; Q2 2025 earnings announced, figures not provided","summary_kind":"llm","event_type":"other_material","confidence":"low","bullets":["Amendment No. 9 to credit facility reduces line of credit to $10M, executed July 17, 2025.","Press release for Q2 2025 and H1 2025 results issued July 21, 2025, but exhibit not included in filing.","Specific financial metrics (revenue, EPS, segment data) unavailable from this filing; confidence low.","No guidance or material operational details disclosed in the 8-K filing body."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":12744761023.361565,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":157639,"accession_number":"0001193125-25-121801","cik":1668397,"company_name":"Medpace Holdings, Inc.","ticker":"MEDP","form_type":"8-K","filed_at":"2025-05-16T23:59:59+00:00","items":["5.02","5.07","9.01"],"status":"ready","headline":"Medpace stockholders approve amended incentive plan and simple majority voting proposal at 2025 annual meeting","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Elected August J. Troendle (21.2M for) and Dani S. Zander (25.9M for) as Class III directors.","Ratified Deloitte & Touche as independent auditor for FY2025 (27.2M for, 600k against).","Advisory vote to approve named executive officer compensation passed (24.9M for).","Approved 2016 Amended and Restated Incentive Award Plan, extending expiration to Feb 6, 2035 (25.6M for).","Non-binding stockholder proposal for simple majority voting approved (18.2M for)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"market_cap_usd":12744761023.361565,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":157638,"accession_number":"0001668397-25-000056","cik":1668397,"company_name":"Medpace Holdings, Inc.","ticker":"MEDP","form_type":"8-K","filed_at":"2025-04-21T23:59:59+00:00","items":["1.01","2.02","8.01","9.01"],"status":"ready","headline":"Medpace increases buyback by $1.0B, expands credit line to $600M; Q1 results released without specifics","summary_kind":"llm","event_type":"other_material","confidence":"low","bullets":["Board approved $1.0B increase to stock repurchase program; timing based on market conditions.","Credit facility amended: line raised to $600M, interest rate adjusted, expiration extended to April 30, 2027.","Q1 2025 earnings press release issued April 21, 2025; specific financial figures not available in this summary.","Credit facility entered with PNC Bank; Amendment No. 8 effective April 18, 2025."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":12744761023.361565,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":176014,"accession_number":"0001668397-25-000037","cik":1668397,"company_name":"Medpace Holdings, Inc.","ticker":"MEDP","form_type":"8-K","filed_at":"2025-03-31T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"Medpace extends revolving credit facility expiration to March 31, 2026","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Amendment No. 7 extends the revolving credit note expiration date to March 31, 2026, representing a one-year extension.","No changes to facility size, interest rate, or other loan terms were disclosed in the amendment.","The amendment was entered into with PNC Bank, National Association, effective March 28, 2025.","Medpace, Inc. is the borrower and Medpace IntermediateCo, Inc. remains the guarantor."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"market_cap_usd":12744761023.361565,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":176013,"accession_number":"0001668397-25-000012","cik":1668397,"company_name":"Medpace Holdings, Inc.","ticker":"MEDP","form_type":"8-K","filed_at":"2025-02-10T23:59:59+00:00","items":["2.02","8.01","9.01"],"status":"ready","headline":"Medpace reports Q4/FY24 earnings (no specifics shown) and boosts buyback by $600M","summary_kind":"llm","event_type":"other_material","confidence":"low","bullets":["Issued press release for Q4 and FY2024 results; no financial figures included in filing.","Board approved $600 million increase to existing stock repurchase program.","Repurchases may be made in open market, private deals, or via Rule 10b5-1 plan.","Program can be discontinued or amended at any time without notice."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":12744761023.361565,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":192936,"accession_number":"0001668397-24-000165","cik":1668397,"company_name":"Medpace Holdings, Inc.","ticker":"MEDP","form_type":"8-K","filed_at":"2024-10-21T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Medpace reports Q3 2024 results; details not available in extracted exhibit text","summary_kind":"llm","event_type":"earnings","confidence":"low","bullets":["Press release dated October 21, 2024, issued under Item 2.02.","Financial results for three and nine months ended September 30, 2024, announced.","Exhibit 99.1 content not provided; specific figures (revenue, EPS, guidance) unknown.","Results are materially significant but raw data missing from the filing extract."],"consensus_eps_estimate":null,"consensus_eps_actual":8.96,"consensus_revenue_estimate":null,"consensus_revenue_actual":1572465000.0,"consensus_period":"2024-Q3","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":12744761023.361565,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":209321,"accession_number":"0001668397-24-000140","cik":1668397,"company_name":"Medpace Holdings, Inc.","ticker":"MEDP","form_type":"8-K","filed_at":"2024-07-22T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Medpace Holdings announces Q2 2024 financial results on July 22, 2024","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Medpace Holdings issued a press release on July 22, 2024, reporting financial results for the three and six months ended June 30, 2024.","The press release is attached as Exhibit 99.1 and incorporated by reference under Item 2.02 of the Form 8-K.","Under Item 9.01, the filing includes Exhibit 99.1 and a Cover Page Interactive Data File (Inline XBRL).","The information is furnished and not deemed filed under the Exchange Act or incorporated by reference into other filings."],"consensus_eps_estimate":null,"consensus_eps_actual":5.96,"consensus_revenue_estimate":null,"consensus_revenue_actual":1039148000.0,"consensus_period":"2024-Q2","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":12744761023.361565,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":209320,"accession_number":"0001193125-24-175077","cik":1668397,"company_name":"Medpace Holdings, Inc.","ticker":"MEDP","form_type":"8-K","filed_at":"2024-07-03T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Medpace director Ashley Keating resigns; Dr. Dani Zander elected to board","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Ashley M. Keating resigned from the Board effective June 30, 2024, with no disagreement on operations, policies, or practices.","Dr. Dani S. Zander elected as Class III director effective July 1, 2024, and appointed to the Nominating and Governance Committee.","Dr. Zander is Chair of Pathology at University of Cincinnati, formerly at Penn State, and has served as president of multiple pathology societies.","Dr. Zander received an option to purchase 824 shares at the July 1, 2024 closing price, with a 7-year term, under standard non-employee director compensation."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":12744761023.361565,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":227299,"accession_number":"0001193125-24-143907","cik":1668397,"company_name":"Medpace Holdings, Inc.","ticker":"MEDP","form_type":"8-K","filed_at":"2024-05-21T23:59:59+00:00","items":["5.03","5.07","9.01"],"status":"ready","headline":"Medpace shareholders approve board declassification; annual director elections start 2025","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Stockholders approved amendment to phase out classified board; directors elected annually beginning at 2025 annual meeting.","Fred B. Davenport Jr. and Cornelius P. McCarthy III elected as Class II directors through 2027.","Deloitte & Touche ratified as independent auditor for fiscal year ending December 31, 2024.","Advisory say-on-pay proposal on named executive officer compensation approved.","Charter amendment and bylaw amendments became effective May 17, 2024."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":12744761023.361565,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":227298,"accession_number":"0001668397-24-000089","cik":1668397,"company_name":"Medpace Holdings, Inc.","ticker":"MEDP","form_type":"8-K","filed_at":"2024-04-22T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Medpace reports Q1 2024 results; exhibit not provided, no specific data available","summary_kind":"llm","event_type":"earnings","confidence":"low","bullets":["Press release filed as Exhibit 99.1 for three months ended March 31, 2024.","No revenue, EPS, or other financial figures are extractable from the available filing text.","Filing indicates earnings announcement but actual results are not included in the provided content."],"consensus_eps_estimate":null,"consensus_eps_actual":3.2,"consensus_revenue_estimate":null,"consensus_revenue_actual":511044000.0,"consensus_period":"2024-Q1","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":12744761023.361565,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":246177,"accession_number":"0001668397-24-000066","cik":1668397,"company_name":"Medpace Holdings, Inc.","ticker":"MEDP","form_type":"8-K","filed_at":"2024-03-29T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"Medpace reduces revolving credit facility from $150M to $10M, extends to March 2025","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Line of credit reduced to $10M from $150M; expiration extended to March 31, 2025.","Amendment adds new compliance representations on anti-corruption, trade sanctions, and anti-money laundering.","Facility remains unsecured; borrower Medpace Inc. and guarantor Medpace IntermediateCo."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":12744761023.361565,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":null}